NCT06083168 Cardiovascular Disease in Patients With Chronic Kidney Disease: Polish Kidney- Heart Project
| NCT ID | NCT06083168 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Silesia |
| Condition | Chronic Kidney Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,000 participants |
| Start Date | 2023-12-01 |
| Primary Completion | 2033-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,000 participants in total. It began in 2023-12-01 with a primary completion date of 2033-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an observational longitudinal study which will collect routine demographic, laboratory and clinical parameters of patients with chronic kidney disease (CKD) in the Silesian and Warmia and Mazury Regions (Poland) aimed at predicting incident cardiovascular disease and cardiovascular and renal events using machine learning and artificial intelligence approaches. There will be a subgroup analysis of patients with diabetes and CKD.
Eligibility Criteria
Inclusion Criteria: * CKD defined as estimated glomerular filtration rate (eGFR) \< 60ml/min/1.73 m2 and/or urine albumin creatinine ratio ( UACR) \> 30 mg/g lasting at least 3 months * CKD regardless of eGFR/albuminuria when documented otherwise (by means of imaging, renal biopsy result, genetic background, etc) Exclusion Criteria: * Death during hospital stay * Terminal stage of cancer * Lack of an informed consent
Contact & Investigator
Katarzyna Nabrdalik, assoc. Prof
PRINCIPAL INVESTIGATOR
Medical University of Silesia
Frequently Asked Questions
Who can join the NCT06083168 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Kidney Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06083168 currently recruiting?
Yes, NCT06083168 is actively recruiting participants. Contact the research team at knabrdalik@sum.edu.pl for enrollment information.
Where is the NCT06083168 trial being conducted?
This trial is being conducted at Olsztyn, Poland, Zabrze, Poland.
Who is sponsoring the NCT06083168 clinical trial?
NCT06083168 is sponsored by Medical University of Silesia. The principal investigator is Katarzyna Nabrdalik, assoc. Prof at Medical University of Silesia. The trial plans to enroll 6,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.